Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/30/2012 | WO2012116328A2 Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival |
08/30/2012 | WO2012116248A1 ALTERNATIVELY SPLICED mRNA ISOFORMS AS PROGNOSTIC INDICATORS FOR METASTATIC CANCER |
08/30/2012 | WO2012116185A1 Methods of detecting aneuploidy in human embryos |
08/30/2012 | WO2012116040A1 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma |
08/30/2012 | WO2012116034A1 Electrophoretic-deposited surfaces |
08/30/2012 | WO2012116019A1 Compositions and methods for detecting bladder cancer |
08/30/2012 | WO2012116001A2 Particles and other substrates useful in protein purification and other applications |
08/30/2012 | WO2012115885A1 Circulating biomarkers |
08/30/2012 | WO2012115851A1 Ultra-high sensitive monitoring of early transplantation failure |
08/30/2012 | WO2012115820A2 Biomarker panels, diagnostic methods and test kits for ovarian cancer |
08/30/2012 | WO2012115770A1 Apparatus and method for estimation of ore quality using color correlations |
08/30/2012 | WO2012115648A1 Compositions and methods for diagnosing and treating kidney disorders in a feline |
08/30/2012 | WO2012115604A1 Mean dna copy number of chromosomal regions is of prognostic significance in cancer |
08/30/2012 | WO2012115493A2 Biomarker for cancer, and cancer diagnosis using same |
08/30/2012 | WO2012115308A1 Method and apparatus for diagnosing thyroid cancer |
08/30/2012 | WO2012115221A1 Method for measuring myocardial troponin |
08/30/2012 | WO2012115185A1 Composition for treatment, amelioration or prophylaxis of pain |
08/30/2012 | WO2012114932A1 Method of evaluating degree of skin stress accumulation |
08/30/2012 | WO2012114708A1 Test substance detection method, and test substance detection chip and test substance detection device using same |
08/30/2012 | WO2012114312A2 Exogenous internal positive control |
08/30/2012 | WO2012114272A1 A method for the prognosis of progression of the hiv disease |
08/30/2012 | WO2012114227A1 Biosensor and method of manufacturing such a biosensor |
08/30/2012 | WO2012114056A1 Capacitance detection in electrochemical assay with improved response |
08/30/2012 | WO2012114055A1 Capacitance detection in electrochemical assay with improved sampling time offset |
08/30/2012 | WO2012114046A1 Arsenic assay using elisa |
08/30/2012 | WO2012113986A1 Particle processing |
08/30/2012 | WO2012113944A1 Apparatus for analysing vegetable products during the processing thereof |
08/30/2012 | WO2012113921A1 Rapid selection method for hiv gp-120 variants |
08/30/2012 | WO2012113911A1 Solid support and method of recovering biological material therefrom |
08/30/2012 | WO2012113907A2 Paper support and method of recovering biological material therefrom |
08/30/2012 | WO2012113906A2 Solid support and method of enhancing the recovery of biological material therefrom |
08/30/2012 | WO2012113834A1 Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants |
08/30/2012 | WO2012113819A1 Molecular biomarkers for predicting response to antitumor treatment in lung cancer |
08/30/2012 | WO2012113801A1 Detection of antibodies using an improved immune complex (ic) elisa |
08/30/2012 | WO2012113784A1 Diagnostic and therapeutic methods |
08/30/2012 | WO2012113775A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
08/30/2012 | WO2012113773A1 Diagnosis of ischemia using sflt-1 and hgf after intervention as an early indicator of complication |
08/30/2012 | WO2012113760A1 Method of predicting the evolution of a patient suffering of stroke |
08/30/2012 | WO2012113718A1 A diagnostic method for type ii diabetes |
08/30/2012 | WO2012113555A1 Myh10 as a new diagnostic marker of pathologies resulting from runx1 inactivation |
08/30/2012 | WO2012113519A1 Method for determining the content of hydrogen disulfide in crude and residual oils |
08/30/2012 | WO2012113481A1 Method and apparatus for diagnosing electrodes in sensor elements |
08/30/2012 | WO2012113371A1 Detection of dimeric catecholamine metabolites as indicators of neurodegenerative diseases |
08/30/2012 | WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof |
08/30/2012 | WO2012113061A1 Cancer diagnosis and treatment |
08/30/2012 | WO2012113032A1 Method, system and apparatus for use in locating subsurface ore bodies |
08/30/2012 | WO2012113028A1 Isolation of a target bioentity from a biological sample |
08/30/2012 | WO2012113022A1 Therapeutic uses of slirp |
08/30/2012 | WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease |
08/30/2012 | WO2012087928A3 Modulating agonistic tnfr antibodies |
08/30/2012 | WO2012083132A3 Diagnosis and treatments relating to th2 inhibition |
08/30/2012 | WO2012065099A3 Portable vacuum gas chromatograph |
08/30/2012 | WO2012049228A3 Marker sequences for multiple sclerosis and the use thereof |
08/30/2012 | WO2012048106A3 Biomarkers useful to predict mek inhibitor drug efficacy |
08/30/2012 | WO2012047341A9 Sapp-alpha as a biomarker for prediction of inflammatory and autoimmune-related disorders |
08/30/2012 | WO2012037486A9 Method and apparatus for encoding test strips |
08/30/2012 | WO2012016107A8 Methods and kits for detection of salmonella enteritidis and related serovars |
08/30/2012 | US20120222171 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
08/30/2012 | US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same |
08/30/2012 | US20120222141 Islet1 (isl1) and hearing loss |
08/30/2012 | US20120222139 Cancer Specific Mitotic Network |
08/30/2012 | US20120221501 Molecular property modeling using ranking |
08/30/2012 | US20120221291 Indoor testing device for a plurality of rotor-containing flying objects |
08/30/2012 | US20120221256 Functional characterization of biological samples |
08/30/2012 | US20120220914 Shrouded Sensor Clip Assembly and Blood Chamber for an Optical Blood Monitoring System |
08/30/2012 | US20120220751 Non-Fluorescent Quencher Compounds and Biomolecular Assays |
08/30/2012 | US20120220671 Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome |
08/30/2012 | US20120220661 Methods of modulation of branched chain acids and uses thereof |
08/30/2012 | US20120220645 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer |
08/30/2012 | US20120220613 Method for determining sensitivity to an anticancer agent |
08/30/2012 | US20120220610 Inhibitions of glutaminase c |
08/30/2012 | US20120220540 Synbodies to akt1 |
08/30/2012 | US20120220534 Biomarker for neurodegeneration in neurological disease |
08/30/2012 | US20120220532 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2 |
08/30/2012 | US20120220524 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples |
08/30/2012 | US20120220519 Peptide Aptamers that Bind to the Rep Proteins of ssDNA Viruses |
08/30/2012 | US20120220495 Arrays of microparticles and methods of preparation thereof |
08/30/2012 | US20120220493 Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
08/30/2012 | US20120220491 Retentate chromatography and protein chip arrays with applications in biology and medicine |
08/30/2012 | US20120220490 Method and compositions for detecting botulinum neurotoxin |
08/30/2012 | US20120220486 Methods and apparatus for binding assays |
08/30/2012 | US20120220480 Method for the detection of renal damage |
08/30/2012 | US20120220476 Biomarkers for ovarian cancer |
08/30/2012 | US20120220471 Nanoantenna and uses thereof for biosensing |
08/30/2012 | US20120220470 Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6 |
08/30/2012 | US20120220469 Toxicity typing using liver stem cells |
08/30/2012 | US20120220055 Method for Detecting Cardiac Ischemia via Changes in B-Natriuretic Peptide Levels |
08/30/2012 | US20120220054 Device for detection of target molecules and uses thereof |
08/30/2012 | US20120220052 Survival prognostic assay |
08/30/2012 | US20120220051 Immunogenicity Assay |
08/30/2012 | US20120220050 Method of purifying 8-isoprostane |
08/30/2012 | US20120220049 Assay method and device |
08/30/2012 | US20120220048 Magnetic marker particle and method for producing the same |
08/30/2012 | US20120220043 Evidence collector with integral quantified reagents and method of modulating specimen drying time |
08/30/2012 | US20120220042 Evidence collector with integral quantified reagents and method of modulating specimen drying time |
08/30/2012 | US20120220038 Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant |
08/30/2012 | US20120219987 Device for electroporation and lysis |
08/30/2012 | US20120219980 System and method for pipetting guidance |
08/30/2012 | US20120219977 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin |
08/30/2012 | US20120219976 Reducing the risk of human anti-human antibodies through v gene manipulation |